Home > Healthcare IT > Veterinary Dermatology Drugs Market Trends by Drug, Animal Type, End Users
Straits Research

Veterinary Dermatology Drugs Market

Veterinary Dermatology Drugs Market: Information by Drug (Antibiotics, Veterinary Antifungal Drugs), Animal Type (Large & Small Animals), End Users (Veterinary Hospitals)—Forecast Till 2026

Table of Content Download Sample

Market Overview

Global veterinary dermatology market is expected to reach  USD 3,525.7 million by 2026 from USD 2,353.9 million in 2018 at a CAGR of 5.5% during the forecast period 2019–2026.

Atopic dermatitis is chronic skin disease associated with allergies which is caused by harmless substances like grass, mold spores, house dust mites, and other environmental allergens. Surge in prevalence of chronic skin disorders such as chewing, biting, rubbing is driving the growth of market. Furthermore, high presence of cattle and buffalo suffering from of lumpy skin disease (LSD) in European countries is major reason for boosting the growth of market. For instance, since 2012, LSD has been spread from Africa and the Middle East into south-eastern Europe, affecting European Union (EU) Member countries. Numerous autoimmune and immune-mediated cutaneous diseases such as atopic in cat and dog across the globe is in companion animals is fuelling the growth of market. Surge in number of incidence of anthrax in cattle, deer, cattle, goats, and sheep is supporting the growth of market.

Market Snapshot

market snapshot
Base Year
: 2017
Study Period
: 2016–2026
: 5.5 %
Fastest Growing Market
: Europe
Largest Market
: North America
Market Size
: 3,525.7 million
Get more information on this report Download Sample Report

Segmental Analysis

The veterinary dermatology drugs market is segmented into drug, animal type and end users.

On the basis of drug the veterinary dermatology drugs market is segmented into non-steroidal anti-inflammatory drugs (NSAIDS), antibiotics, and veterinary antifungal drug. Antibiotics veterinary medicine segment is expected to hold major market share owing to most of skin diseases caused by various bacteria.

Based on the animal type the market is segmented into large animals and small animals. High prevalence of dermatological disorders in small animals such as dog and cat as compared other animal, thus, small animals segment is dominated market and expected to grow in forecast period.

On the basis of end users the market is segmented into veterinary hospitals, veterinary clinics. Veterinary clinics is expected to hold major market share owing to control infectious animal diseases and thus reduce morbidity and mortality rate of animals. Veterinary clinics is cost effective then veterinary hospital thus, large number of patient visit the clinic.

Regional Analysis

Geographically, veterinary dermatology drugs market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).

North America is dominating the market & is expected to continue its dominance over the forecast period. This is attributed to increasing adoption of companion animal in developed countries such as U.S., Canada and increasing spending on pet care in this region is boosting the growth of market. For instance, as per American Pet Products Association (APPA) data states that 68.0% of US households, or approximately 86.4 million homes, have at least one pet. However, high prevalence of pruritus, sores, alopecia, masses, eruptions, scales, seborrhea, pustules, and draining tracts in companion animals is fuelling the market growth. Furthermore, increasing technology in veterinary medicine that has lengthen lifespan of veterinary animals is another region which positively influence the market.

Europe is expected to witness second leading region for veterinary dermatology drugs market. Different dermatological association in Europe region which is increasing the awareness about the skin disease is boosting the growth of market. For instance, European Society of Veterinary Dermatology, is a non-profit organization that supports the development of veterinary dermatology throughout Europe and provides funding for both research and educational programs such as workshops. Presence of leading animal care player such as International GmbH.(France), Vetoquinol S.A.(France), and Virbac(France). is positively impact on market.

Veterinary Dermatology Drugs Market Regional Analysis
Regional Growth Insights Download Free Sample

Top Key Players of Veterinary Dermatology Drugs Market

Some of the key players in global veterinary dermatology drugs market include 

  1. Bayer HealthCare Animal Health Inc. (U.S.),
  2. Boehringer Ingelheim Vetmedica, Inc.(U.S.),
  3. Ceva(France),
  4. Zoetis Inc.(U.S.),
  5. Elanco(U.S.),
  6. IDEXX Laboratories(U.S.),
  7. Boehringer Ingelheim International GmbH.(France),
  8. Vetoquinol S.A.(France),
  9. Virbac(France).

Report Scope

Report Metric Details
CAGR 5.5%
Forecast Period 2023-2031
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered
  1. By Drug
    1. Non-steroidal anti-inflammatory drugs (NSAIDS)
    2. Antibiotics
    3. Veterinary antifungal drug
  2. By Animal Type
    1. Large animals
    2. Small animals
  3. By End Users
    1. Veterinary Hospitals
    2. Veterinary Clinics
Geographies Covered
  • North America
  • Europe
  • APAC
  • Middle East and Africa

Veterinary Dermatology Drugs Market Segmentation

By Drug

  • Non-steroidal anti-inflammatory drugs (NSAIDS)
  • Antibiotics
  • Veterinary antifungal drug

By Animal Type

  • Large animals
  • Small animals

By End Users

  • Veterinary Hospitals
  • Veterinary Clinics

By Regional


o    North America

  • U.S.
  • Canada
  • Mexico

o    South America


  • Western Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Rest of Western Europe

o    Eastern Europe

      Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific

     The Middle East & Africa

  • The Middle East
  • Saudi Arabia
  • UAE
  • Qatar
  • Rest of the Middle East
Price Starts From
USD 995

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report
Want to learn more about recent trends and data ?
They Already Trust Us :
Nippon Becton Dickinson
Argon Medical Devices
Johnson & Johnson
Need Assistance?
+1 646 480 7505 (U.S.)
+44 208 068 9665 (U.K.)

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track sales in the global and country-specific Market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Report Snapshot
Looking For Custom Report ?
Check Our License Options :

As featured on :

Trusted by Fortune 500
Over 30000+ subscribers